Which lung test is best for scleroderma patients?
NCT ID NCT05505617
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two commercially available devices that measure how well the lungs transfer nitric oxide and carbon monoxide. Nine adults with systemic sclerosis and related lung disease took part. Each person was tested with both devices in random order to see if the results differ. The goal was to understand whether device choice matters in people with lung impairment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the right device for measuring lung function in people with scleroderma-related lung disease.
- What could go wrong
- This is a very small, completed study with only 9 participants. It does not test a treatment, so it cannot directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Zurich
Zurich, Canton of Zurich, 8001, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI catch lung scarring that doctors might miss?
- Can arm workouts boost oxygen use in lung disease?
- Immune clues in the blood may foretell heart trouble
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Blood particles may reveal hidden clues to scleroderma complications
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD